Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

CVS Caremark (CVS - Analyst Report) is scheduled to report its first-quarter 2013 results before the opening bell on May 1. In the last quarter, CVS Caremark reported a 2.73% positive earnings surprise on the heels of robust growth across both operating platforms. Let us see how things are shaping up for this integrated pharmacy services provider prior to the announcement. 
 
Factors to Consider this Past Quarter
 
CVS Caremark’s bright prospects for 2013 on the heels of solid earnings forecast, stronger balance sheet, favorable selling season and positive industry dynamics are encouraging. On the domestic front, demographic trends, healthcare reforms in the U.S., and the generic wave in the pharmaceutical industry are expected to catalyze growth for the company. In light of these trends, CVS Caremark expects accelerating adoption of its programs such as Maintenance Choice, Pharmacy Advisor and ExtraCare loyalty program, along with expansion of its MinuteClinics. 
 
As per management, the company continues to win market share in retail pharmacy. In the meantime, the tussle with Walgreens (WAG - Analyst Report) to gain market share has intensified. Macroeconomic uncertainty is another looming concern. 
 
Earnings Whispers?
 
Our proven model does not conclusively show that CVS Caremark is likely to beat earnings estimate this quarter. That is because a stock needs to have both a positive Earnings ESP (Read: Zacks Earnings ESP: A Better Method) and a Zacks Rank of #1, 2 or 3 for this to happen. This is not the case here, as you will see below.
 
Zacks Earnings ESP: The Most Accurate estimate stands at 78 cents, while the Zacks Consensus Estimate is pegged at 79 cents. This comes to a difference of -1.27%.
 
Zacks Rank #2 (Buy): CVS Caremark’s Zacks Rank #2 diffuses the predictive power of ESP. The Zacks Rank #2 together with -1.27% earnings ESP makes surprise prediction difficult.
 
Other Stocks to Consider
 
Here are some other companies from the healthcare sector you may want to consider as our model shows they have the right ingredients to post an earnings beat this quarter:
 
Coventry Health Care Inc. ,  Earnings ESP of +5.06% and Zacks Rank #2 (Buy) 
 
Henry Schein (HSIC - Analyst Report), Earnings ESP of +3.74% and Zacks Rank #3 (Hold)CVS Caremark (CVS - Analyst Report) is scheduled to report its first-quarter 2013 results before the opening bell on May 1. In the last quarter, CVS Caremark reported a 2.73% positive earnings surprise on the heels of robust growth across both operating platforms. Let us see how things are shaping up for this integrated pharmacy services provider prior to the announcement. 
CVS Caremark (CVS - Analyst Report) is scheduled to report its first-quarter 2013 results before the opening bell on May 1. In the last quarter, CVS Caremark reported a 2.73% positive earnings surprise on the heels of robust growth across both operating platforms. Let us see how things are shaping up for this integrated pharmacy services provider prior to the announcement. 
 
Factors to Consider this Past Quarter
 
CVS Caremark’s bright prospects for 2013 on the heels of solid earnings forecast, stronger balance sheet, favorable selling season and positive industry dynamics are encouraging. On the domestic front, demographic trends, healthcare reforms in the U.S., and the generic wave in the pharmaceutical industry are expected to catalyze growth for the company. In light of these trends, CVS Caremark expects accelerating adoption of its programs such as Maintenance Choice, Pharmacy Advisor and ExtraCare loyalty program, along with expansion of its MinuteClinics. 
 
As per management, the company continues to win market share in retail pharmacy. In the meantime, the tussle with Walgreens (WAG - Analyst Report) to gain market share has intensified. Macroeconomic uncertainty is another looming concern. 
 
Earnings Whispers?
 
Our proven model does not conclusively show that CVS Caremark is likely to beat earnings estimate this quarter. That is because a stock needs to have both a positive Earnings ESP (Read: Zacks Earnings ESP: A Better Method) and a Zacks Rank of #1, 2 or 3 for this to happen. This is not the case here, as you will see below.
 
Zacks Earnings ESP: The Most Accurate estimate stands at 78 cents, while the Zacks Consensus Estimate is pegged at 79 cents. This comes to a difference of -1.27%.
 
Zacks Rank #2 (Buy): CVS Caremark’s Zacks Rank #2 diffuses the predictive power of ESP. The Zacks Rank #2 together with -1.27% earnings ESP makes surprise prediction difficult.
 
Other Stocks to Consider
 
Here are some other companies from the healthcare sector you may want to consider as our model shows they have the right ingredients to post an earnings beat this quarter:
 
Coventry Health Care Inc. ,  Earnings ESP of +5.06% and Zacks Rank #2 (Buy) 
 
Henry Schein (HSIC - Analyst Report), Earnings ESP of +3.74% and Zacks Rank #3 (Hold)

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
BITAUTO HOLD BITA 33.81 +9.88%
NOAH HOLDING NOAH 13.97 +5.12%
INTERNATIONA ICAGY 33.09 +4.72%
CHINA DISTAN DL 14.83 +4.55%
GENTHERM INC THRM 36.30 +4.43%